Jan-Michael Peters
| Jan-Michael Peters | |
|---|---|
| Born |
16 August 1962 Schleswig-Holstein, Germany |
| Residence | Vienna, Austria |
| Citizenship | German |
| Alma mater |
|
| Awards |
|
| Scientific career | |
| Fields | cell biology, molecular biology |
| Institutions | |
| Thesis | (1991) |
| Doctoral advisor | Werner Franke |
Jan-Michael Peters (born 16 August 1962 in Schleswig-Holstein, Germany) is a cell- and molecular biologist. Since 2013, he is Scientific Director of the Research Institute of Molecular Pathology (IMP) in Vienna.
Jan-Micheal Peters grew up in Schleswig-Holstein and referred to an interest in biology that goes back to his childhood.
Peters started studying at the University of Kiel in 1982, where he received his pre-diploma in Biology. In 1988, he completed his diploma studies at the University of Heidelberg, where he also obtained his PhD in cell biology in 1991. Working with Werner Franke during his PhD studies, Peters discovered p97-ATPase and first characterized the 26S proteasome.
Between 1992 and 1993, Peters continued working with Werner W. Franke as a postdoctoral fellow at the German Cancer Research Center DKFZ in Heidelberg, where he worked on the first purification and electron microscopy of 26S proteasome..
In 1994, Peters joined the lab of Marc W. Kirschner at Harvard Medical School in Boston as a postdoctoral fellow. There, he discovered the anaphase promoting complex/cyclosome (APC/C) and other enzymes required for chromosome segregation.
In 1996, Peters moved to Vienna to become Junior Group Leader at the Research Institute of Molecular Pathology (IMP), and was promoted to Senior Scientist in 2002. In 2011, he became the institute’s Scientific Deputy Director and in 2013 Scientific Director, succeeding Barry Dickson.
Peters’ research group studies the molecular mechanisms of chromosome organization, chromosome segregation and cell division in a variety of model organisms.
...
Wikipedia